Immunotherapies - GEN - Genetic Engineering and Biotechnology News

Immunotherapies

Sigmoid Pharma to Acquire Freund Pharmatec

Immunotherapies

ImmunoCellular Therapeutics Chooses PCT for Supply of Glioblastoma Vaccine Candidate

Immunotherapies

FDA Clears Novartis’ Zortress for Preventing Organ Rejection in Kidney Transplant Patients

Immunotherapies

Agennix Contracts DSM for Commercial Supply of a Dendritic Cell Mediated Immunotherapy

Immunotherapies

Fate Therapeutics, MSK to Develop Off-the-Shelf T-Cell Immunotherapies

Immunotherapies

CAR T-Cell Immunotherapy Proves a Plus in Treatment-Resistant Chronic Lymphocytic Leukemia

Immunotherapies

Immunotherapy Approaches against Chronic Form of Leukemia Emerge

Immunotherapies

Immunotherapy for Egg Allergy Shows Promise in Long-Term Study

Immunotherapies

Lilly, Sanford-Burnham Launch Immunological Immunotherapy Collaboration

Immunotherapies

Gilead to Acquire Forty Seven for $4.9B, Expanding Immuno-Oncology Pipeline

Human microbiome, conceptual illustration

Immunotherapies

Engineered Probiotic Bacteria Deliver Anticancer Nanobodies to Regress Tumors in Mice

Immunotherapies

Pancreatic Cancer Research Gets $25M Boost

Immunotherapies

AstraZeneca, Accent Launch up to $1.1B+ Cancer Collaboration Targeting RNA-Modifying Proteins

Immunotherapies

GSK Taking Aim at Cancer in MD Anderson’s Moon Shots Program

Immunotherapies

Evotec and Apeiron Biologics Collaborate on Cancer Immunotherapy

12 3...64 Page 1 of 64